Shandong Wohua Pharmaceutical Co., Ltd. (002107.SZ)

CNY 5.22

(-0.57%)

Market Cap (In CNY)

3.01 Billion

Revenue (In CNY)

894.31 Million

Net Income (In CNY)

58.76 Million

Avg. Volume

5.62 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
3.2-6.52
PE
122.5
EPS
0.04
Beta Value
0.235
ISIN
CNE000001QB8
CUSIP
-
CIK
-
Shares
577210000.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Ms. Yingzi Zeng
Employee Count
-
Website
https://www.wohua.cn
Ipo Date
2007-01-24
Details
Shandong Wohua Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in China. It offers Xinkeshu tablets, Naoxueshu oral solutions, Tongluo Huayu capsules, and oral liquids for cardiovascular and cerebrovascular; respiratory system drugs; medicines for women and children; urinary system drugs; digestive system drugs; anti-rheumatic drugs; and drugs for soothe the nerves. The company is based in Weifang, China. Shandong Wohua Pharmaceutical Co., Ltd. is a subsidiary of Beijing Zhongzheng Wanrong Investment(Group) Co., Ltd.